stem cell transplantation

Related by string. Stem Cell Transplantation * stems . STEM . Stems : stem cell research . adult stem cells . adult stem cell / Cells . Cell : Q Cells AG . Fuel Cell / Transplantation . transplantations : often accompany transplantations . liver transplantation * stem cell transplantation SCT . Hematopoietic Stem Cell Transplantation . Autologous Stem Cell Transplantation *

Related by context. All words. (Click for frequent words.) 70 bone marrow transplantation 68 cell transplantation 68 transplantation 67 stem cell transplant 65 stem cell transplants 63 renal transplantation 62 bone marrow transplants 62 stem cell therapy 61 transplantations 61 transplantation HCT 61 liver transplantation 60 allogeneic 60 transplantation HSCT 60 Islet transplantation 59 organ transplantation 59 myeloablative 59 allogeneic transplant 59 lung transplantation 59 allogeneic stem cell 59 transplanting stem cells 59 kidney transplantation 58 corneal transplantation 58 allogeneic transplants 58 autologous transplant 58 solid organ transplantation 58 hematopoietic stem cell 58 bone marrow stem cells 57 bone marrow transplant 57 hematopoietic cell 57 immunosuppression 57 allogeneic SCT 57 allogeneic hematopoietic stem cell 57 allogeneic bone marrow 57 renal transplant 57 bone marrow stem cell 57 stem cells 57 stem cell transplantations 56 allogenic 56 engraftment 56 autologous transplants 56 islet transplantation 56 ovarian stimulation 56 cells hESCs 56 pancreatic adenocarcinoma 56 autologous 56 pancreatic islet cell 56 transplant HSCT recipients 56 donor pancreases 56 cytotoxic chemotherapy 55 hematopoietic stem cells 55 curative therapy 55 platelet transfusions 55 transplant ASCT 55 haematopoietic 55 donor nephrectomy 55 CMV disease 55 haematopoietic stem cell 55 HSCT 55 neural stem cell 55 adult stem cells 55 autologous transplantation 55 transplant HSCT 55 chronic granulomatous disease 55 islet transplant 55 stem cell engraftment 55 Hematopoietic stem cell 54 umbilical cord stem cells 54 malignant transformation 54 ASCT 54 liver resection 54 hematopoietic 54 immunosuppressive drugs 54 lung transplants 54 Hepatocellular Carcinoma HCC 54 Autologous 54 radical cystectomy 54 hES cells 54 LDLT 54 cytoreduction 54 transplantation ASCT 54 Vitro Fertilization IVF 54 stem cell therapies 54 HLA matched 54 metastatic RCC 54 renal tumors 54 immunotherapy 54 hypophosphatasia 54 intravesical therapy 54 retinoblastoma 54 allogeneic HSCT 53 Liver transplantation 53 leukemia ALL 53 colorectal liver metastases 53 lymph node dissection 53 transdifferentiation 53 hepatectomy 53 haematological malignancies 53 cystectomy 53 adipose derived stem cells 53 reimplantation 53 DSAEK 53 malignant pleural mesothelioma 53 fetal stem cells 53 gene therapy 53 regenerative medicine 53 autologous hematopoietic stem cell 53 ES cells 53 islet transplants 53 aortic dissections 53 cranial radiation 53 marrow transplant 53 lupus nephritis 53 beta thalassemia 53 bevacizumab Avastin ® 53 autologous SCT 53 autologous stem cell 53 neural cells 53 haematological cancers 53 allogeneic hematopoietic cell 53 antithrombotic therapy 52 multiple myeloma MM 52 GvHD 52 TACE 52 adult mesenchymal stem 52 bone marrow derived 52 Allogeneic 52 transarterial chemoembolization 52 GIST tumors 52 pluripotent stem cell 52 colorectal cancer liver metastases 52 myelofibrosis 52 hematopoietic cells 52 radical nephrectomy 52 nephrectomy 52 therapies 52 retroviral vectors 52 glioblastoma 52 mismatched bone marrow 52 immunosuppressive medication 52 tumor resection 52 Peripheral Blood 52 vitro fertilization IVF 52 Gleevec resistant 52 azacitidine 52 stem cell 52 regenerative medicine therapies 52 renal denervation 52 radioiodine therapy 52 pro angiogenic 52 ReN# 52 myelodysplastic syndrome MDS 52 myocardial revascularization 52 ATIR TM 52 pancreatic islets 52 immunosuppressive therapy 52 CMV infection 52 leukaemic stem cells 52 JAK3 52 bone marrow transplantations 52 pulmonary artery banding 52 pancreatic tissue 52 neuronal stem cells 52 placental stem cells 52 GVHD 52 iPS cells 52 Hurler syndrome 52 thymectomy 52 invasive candidiasis 52 regenerative therapy 51 Adult stem cells 51 pluripotent stem cells 51 iPS cell 51 nephron sparing surgery 51 pancreatic islet cells 51 Umbilical cord stem cells 51 immune suppression 51 hepatocellular carcinoma 51 cord blood 51 chronic GVHD 51 marrow transplantation 51 antiviral therapy 51 imatinib 51 neuroblastomas 51 induced pluripotent cells 51 axillary dissection 51 myeloproliferative neoplasms 51 prenatal diagnosis 51 myeloproliferative diseases 51 transplant 51 bypass grafting 51 hematologic disorders 51 hematopoietic blood 51 iPSC 51 vasectomy reversal 51 PTLD 51 chemoradiotherapy 51 transfusion 51 nonmyeloablative 51 allogeneic HCT 51 adjuvant radiotherapy 51 sorafenib Nexavar 51 mesenchymal stem cells MSCs 51 transfusions 51 gastrointestinal stromal tumors 51 ATIR 51 corneal transplants 51 optica 51 warfarin therapy 51 Cystectomy 51 Neural stem cells 51 Waldenstrom macroglobulinemia 51 myelodysplastic syndromes MDS 51 IV NSCLC 51 autologous bone marrow 51 CMV reactivation 51 erythropoiesis 51 Telintra 51 TURP 51 metastatic renal cell carcinoma 51 pharmacologic intervention 51 therapeutic regimens 51 therapeutic modalities 51 depsipeptide 51 liver metastases 51 non myeloablative 51 Mesenchymal 51 malignancies 51 ovarian hyperstimulation 51 pancreatectomy 51 pancreatic transplantation 51 adrenalectomy 51 pluripotent cells 51 CMV seropositive 51 islet cells 51 domino transplant 51 multiple myeloma 51 leukemia AML 51 medulloblastoma 51 endovascular aneurysm repair 50 neoplastic 50 bone marrow derived mesenchymal 50 hepatic metastases 50 pancreatic islet 50 Mesenchymal stem cells 50 umbilical cord blood 50 CABG surgery 50 immunosuppressant drugs 50 robotic prostatectomy 50 metastatic colon cancer 50 myeloproliferative disorders 50 IV tPA 50 5-fluorouracil/leucovorin 50 elective PCI 50 ADPKD 50 neoadjuvant chemotherapy 50 TELINTRA 50 allogeneic transplantation 50 Surgical resection 50 Progenitor cells 50 iPSCs 50 Lung transplantation 50 trastuzumab Herceptin 50 partial nephrectomy 50 etoposide 50 HIPEC 50 Stem Cell Therapy 50 diabetic retinopathy DR 50 hematopoietic malignancies 50 intra arterial chemotherapy 50 sentinel lymph node biopsy 50 cells MSCs 50 Neo Bladder Augment 50 Doxil ® 50 chemotherapy regimens 50 dyskeratosis congenita 50 radiation therapy SBRT 50 transplanted stem cells 50 haematologic 50 neoadjuvant therapy 50 ependymoma 50 Li Fraumeni Syndrome 50 endovascular repair 50 polycythemia vera essential thrombocythemia 50 noninvasive imaging 50 heavily pretreated 50 bioartificial liver 50 immunosuppressive regimens 50 thoracoscopic lobectomy 50 antisense oligonucleotides 50 pancreatic 50 metastatic melanoma 50 hESCs 50 YONDELIS 50 rFVIIa 50 orchiectomy 50 thymic carcinoma 50 biotherapy 50 mesenchymal stem cell 50 revascularization 50 systemic fungal infections 50 T1DM 50 microsphere therapy 50 romiplostim 50 hypercholesterolemia 50 NOD SCID mice 50 panobinostat 50 immunosuppression therapy 50 mesenchymal stem cells 50 anticancer therapy 50 Tamibarotene 50 revascularisation 50 leukapheresis 50 cranial irradiation 50 neurotrophic 50 cervical carcinoma 50 cochlear implantation 50 grade cervical intraepithelial 50 retinal degeneration 50 xenotransplantation 50 sickle cell disease 50 OPCAB 50 von Willebrand disease 50 essential thrombocythemia 50 immunosuppressive therapies 50 transcatheter aortic valve implantation 50 rituximab 50 Bone marrow transplantation 50 interferon IFN 50 relapsed ALL 50 hESC lines 50 multipotent 50 prostate carcinoma 50 FVIIa 50 monoclonal antibody therapies 50 cardiac transplantation 50 gefitinib Iressa 50 kidney transplant 50 renal transplants 50 haematologic malignancies 50 cellular immunotherapy 50 cytoreductive nephrectomy 50 extracorporeal membrane oxygenation 50 decitabine 50 remyelination 50 mouse neural stem 50 engrafted cells 50 ABO incompatible 50 Immunosuppressive drugs 50 temozolomide 50 primitive neuroectodermal tumor 50 donor liver transplantation 50 recurrent ovarian cancer 50 reperfusion injury 50 MAPCs 50 chronic myelogenous leukemia CML 50 pelvic lymph node dissection 50 vascular anomalies 50 metastatic malignant 50 keratoplasty 50 bone marrow stromal cells 50 acinar cells 50 deriving stem cells 50 Revimmune 50 mutated EGFR 50 hematological cancers 50 oral anticoagulants 50 stem cell differentiation 50 enucleation 50 primary immunodeficiencies 49 cryopreserved 49 urothelial cancer 49 pig islets 49 HbF 49 pancreaticoduodenectomy 49 regenerative therapies 49 HAART 49 lentiviral 49 recombinant erythropoietin 49 Symadex 49 pneumonectomy 49 cyclosporin 49 IRX 2 49 pancreatic NET 49 facial transplantation 49 mononuclear cells 49 cartilage regeneration 49 kidney urologic 49 cytoreductive surgery 49 Adult Stem Cells 49 oocytes 49 mutated K ras 49 JAK STAT signaling 49 hemodilution 49 chemotherapies 49 bone marrow 49 myeloproliferative disorder 49 apheresis 49 coronary intervention 49 carotid artery stenting 49 thalidomide Thalomid 49 Xanafide 49 immunoregulation 49 chemotherapeutic agents 49 biologic therapy 49 TNFa 49 immunosuppressants 49 R0 resection 49 neural progenitor cells 49 embryonic stem cells ESCs 49 recurrent glioblastoma multiforme 49 coronary artery bypass grafting 49 acute myelogenous leukemia AML 49 uterine fibroid embolization 49 tumor recurrence 49 INFUSE ® 49 small molecule activators 49 Stem Cell Transplant 49 G CSF 49 transplants CBTs 49 acute GvHD 49 Chronic myeloid leukemia CML 49 retransplantation 49 chemoradiation 49 adverse cytogenetics 49 AV grafts 49 MYCN amplification 49 hematological diseases 49 endocrine pancreas 49 MMP inhibitors 49 antireflux surgery 49 unspecialized cells 49 Mantle Cell Lymphoma 49 MyVax ® 49 Severe Primary IGFD 49 hepatocellular carcinoma HCC 49 induced pluripotent stem iPS 49 recurrent glioblastoma 49 gastrointestinal stromal tumor 49 hydroxyurea 49 CD# + [001] 49 critical limb ischemia 49 smoldering myeloma 49 hematopoietic progenitor cells 49 recurrent glioma 49 idarubicin 49 tyrosine kinase inhibitor 49 vWD 49 pathogen inactivation 49 donor marrow 49 trabeculectomy 49 prostate adenocarcinoma 49 vitro maturation 49 Alocrest 49 HSPCs 49 clefting 49 grafts 49 investigational monoclonal antibody 49 ImmuKnow 49 neoplastic cells 49 relapsed multiple myeloma 49 interferon therapy 49 angiosarcoma 49 epithelial tissue 49 liver grafts 49 immunotherapies 49 intestinal stem cells 49 gastrointestinal stromal tumors GIST 49 hpSCs 49 Corgentin 49 C1 INH 49 Myelodysplastic Syndrome 49 PLX cells 49 Kidney transplantation 49 Inhaled nitric oxide 49 cilengitide 49 lenalidomide Revlimid R 49 intracytoplasmic sperm injection 49 glioblastoma multiforme GBM 49 sentinel node biopsy 49 leukemic stem cells 49 Alessandro Riva 49 liver transplant recipients 49 TAVI 49 proliferative diabetic retinopathy 49 immunosuppressive agents 49 leukoreduction 49 WT1 49 neurotrophic factors 49 HuCNS SC cells 49 anti angiogenic agents 49 CEQ# 49 Belldegrun 49 palliation 49 embryonic stem cells 49 colon carcinoma 49 neural stem cells 49 FLT3 49 imatinib Gleevec 49 rBChE 49 PARP inhibitors 49 diagnosed multiple myeloma 49 CMV vaccine 49 PNH patients 49 hpSC 49 stem cells harvested 49 Factor VIIa 49 gastrointestinal cancers 49 neoadjuvant 49 chemotherapeutic regimens 49 INGAP 49 invasive aspergillosis 49 hematopoiesis 49 therapeutic interventions 49 postoperative morbidity 49 MGd 49 HSCs 49 kidney pancreas 49 homozygous FH 49 GeoVax vaccine 49 Meningiomas 49 cerebral angiography 49 relapsed ovarian cancer 49 postoperative atrial fibrillation 49 TEMODAL 49 nonpharmacologic 49 imatinib therapy 49 colorectal carcinoma 49 Transplantation 49 Bone marrow transplant 49 Radical prostatectomy 48 Kit CD# positive 48 Vascugel ® 48 solid tumors 48 hematopoetic stem cells 48 hESC derived 48 anthracyclines 48 basal cell nevus syndrome 48 NPM1 48 hematological malignancy 48 viral inactivation 48 carcinoid tumors 48 organ transplants 48 GRNCM1 48 myelofibrosis polycythemia vera 48 blastomere 48 hematologic malignancies 48 Halaven 48 Azacitidine 48 pancreatic carcinoma 48 antiangiogenic drugs 48 teratomas 48 HUCB cells 48 steroid refractory 48 juvenile myelomonocytic leukemia 48 B CLL 48 neuroendocrine tumors 48 revascularization procedure 48 refractory acute myeloid 48 mitral valve repair 48 imatinib resistant 48 superficial bladder cancer 48 squamous cell carcinoma SCC 48 #beta HSD1 48 CBLC# 48 mycophenolate mofetil 48 recurrent GBM 48 corneal transplant 48 interventional therapies 48 antibody mediated 48 proliferative retinopathy 48 TEVAR 48 extracorporeal membrane oxygenation ECMO 48 bladder carcinoma 48 external beam radiotherapy 48 activin 48 transgenic rats 48 recurrent prostate cancer 48 acute myeloid leukemia AML 48 thymosin 48 clinical trials 48 tamoxifen therapy 48 dose melphalan 48 cardiac surgery 48 operable breast cancer 48 hormonal therapies 48 hepatitis C HCV 48 NGAL 48 fibrotic disease 48 proteomic analysis 48 Corneal transplants 48 immunosuppressive medications 48 GnRH agonists 48 syngeneic 48 allografts 48 Fanconi anemia 48 stem cells derived 48 medulloblastomas 48 thoracic aortic aneurysms 48 Transfusions 48 iron overload 48 IVF ICSI 48 DALK 48 TNF alpha antagonist 48 portal vein thrombosis 48 immunopathology 48 Vorinostat 48 homozygous familial hypercholesterolemia 48 temsirolimus 48 Islet cell 48 carotid surgery 48 5q deletion 48 thalassemia 48 valve implantation 48 gene expression profiling 48 microsatellite instability 48 Revlimid lenalidomide 48 p#INK#a 48 iron chelation therapy 48 human parthenogenetic stem 48 IDH1 mutation 48 HoLEP 48 alkylating agents 48 extrapleural pneumonectomy 48 thrombolytics 48 metastatic lung cancer 48 GISTs 48 elacytarabine 48 ovarian carcinoma 48 fulvestrant 48 coronary stenting 48 onset diabetes mellitus 48 vitro 48 primordial germ cells 48 androgen deprivation 48 gastrointestinal GI cancers 48 DMARD therapy 48 parthenogenetic stem cells 48 adjuvant therapy 48 ex vivo 48 autoimmune encephalitis 48 adipose stem cells 48 atypical Hemolytic Uremic Syndrome 48 thromboembolic disease 48 epithelial tumors 48 cidofovir 48 grade gliomas 48 thiopurine drugs 48 Rituximab 48 Sertoli cells 48 thyroidectomy 48 immunosuppressant medications 48 refractory angina 48 immunochemical fecal occult 48 Vascugel 48 LC#m# 48 Certican 48 Carotid stenting 48 immunosuppressive 48 radiochemotherapy 48 belatacept 48 metastatic bladder 48 familial amyloidotic polyneuropathy FAP 48 transplanted neural stem 48 ISF# 48 pancreatic neuroendocrine tumors 48 FVIII 48 chemoresistance 48 TORISEL 48 immunomodulatory therapy 48 Stem Cell Transplantation 48 vitro fertilization 48 Velcade bortezomib 48 cerebral vasospasm 48 Torisel 48 care regimens CCR 48 Hodgkin lymphoma HL 48 hA# 48 diagnosis PGD 48 Leber Congenital Amaurosis LCA 48 humanized mouse 48 sunitinib 48 leukemia CLL 48 induce pluripotency 48 pediatric acute lymphoblastic 48 colony stimulating factors 48 pelvic lymphadenectomy 48 ocular disorders 48 dedifferentiation 48 prognostic markers 48 RPE# 48 immune modulator 48 lung resection 48 revision hip arthroplasty 48 mRCC 48 peginterferon 48 renal allograft 48 relapsed refractory 48 ALN TTR# 48 Mitral valve repair 48 autoimmunity 48 CTAP# Capsules 48 cadaveric donor 48 penetrating keratoplasty 48 PGD 48 transurethral resection 48 myeloid cells 48 implantation genetic 48 Chronic lymphocytic leukemia 48 Chronic Myeloid Leukemia CML 48 postoperative pulmonary 48 anticancer therapies 48 radionuclide therapy 48 transplanted bone marrow 48 exon skipping 48 relapsed leukemia 48 assisted reproduction 48 antiretroviral regimens 48 leukaemic cells 48 GRNOPC1 cells 48 anti angiogenic drugs 48 immunosuppressed patients 48 fertility treatments 48 imetelstat 48 pDCs 48 HER2 positive metastatic breast 48 ovarian tissue 48 IVIG therapy 48 IGIV 48 VSELs 48 myeloproliferative disease 48 ELACYT 48 coronary revascularization 48 umbilical cord stem cell 48 cells PBMC 48 noninfectious uveitis 48 Liver transplants 48 mitomycin C 48 cytogenetics 48 B lymphocyte 48 Nilotinib 48 HLA typing 48 corticosteroid therapy 48 Myelodysplastic Syndrome MDS 48 Bone marrow derived 48 demethylation 48 endoscopic surgery 48 EGFR inhibitors 48 NF kB pathway 48 hair follicle stem cells 48 stage IIIB 48 breast cancer metastasis 48 Pervasis 48 inherited metabolic disorders 48 bladder augmentation 48 immunological 48 microsurgical techniques 47 recombinant FSH 47 chemotherapy 47 hypertrophic scars 47 trophoblast cells 47 neuroendocrine cancers 47 androgen receptor AR 47 mimetics 47 reinnervation 47 LHON 47 Allovectin 7 ® 47 Immunotherapy 47 neoadjuvant treatment 47 tissue grafts 47 pediatric liver transplants 47 CellCept mycophenolate mofetil 47 saphenous vein grafts 47 nerve regeneration 47 prospective multicenter study 47 erlotinib Tarceva ® 47 Sym# 47 palifermin 47 polycythemia vera PV 47 chimerism 47 unresectable liver cancer 47 breast carcinomas 47 tissue fibrosis 47 effector function 47 aneuploidy screening 47 craniofacial 47 Follicular Lymphoma 47 Circulating tumor cells 47 neuronal differentiation 47 curative resection 47 taxane chemotherapy 47 teratoma 47 adoptive immunotherapy 47 hemodialysis 47 myelodysplastic syndrome 47 chronic lymphocytic leukemia CLL 47 epigenetic mechanisms 47 antiretroviral therapy 47 immune reconstitution 47 NF2 47 allogenic stem cell 47 intravenous immunoglobulin 47 geldanamycin 47 cholecystectomy 47 nonsmall cell lung cancer 47 thrombolytic agents 47 Neulasta ® 47 lung transplantations 47 cyclophosphamide 47 tyrosine kinase inhibitors 47 pulmonary hypertension PH 47 transplanted kidneys 47 dexanabinol 47 HRPC 47 pancreatic endocrine 47 idiopathic myelofibrosis 47 islet cell 47 rFVIIIFc 47 cardiac dysfunction 47 autologous adult 47 angiogenesis inhibition 47 Intravenous CP 47 chemoembolization 47 activated lymphocytes 47 taxane therapy 47 intravenous bisphosphonates 47 HuCNS SC ® 47 ACZ# 47 oncologic outcomes 47 antiplatelet therapy 47 ICD implantation 47 Leydig cells 47 immunologically compatible 47 adjuvant radiation 47 Mitomycin C 47 renal carcinoma 47 metastatic neuroendocrine tumors 47 MEK inhibitors 47 idiopathic pulmonary fibrosis IPF 47 calcineurin inhibitor 47 brain metastases 47 immunocompetent 47 Trastuzumab 47 HAART regimens 47 metastatic prostate cancer 47 anti leukemic 47 MyVax R 47 Acute Myeloid Leukemia AML 47 adipogenic 47 hemofiltration 47 urothelial bladder cancer 47 ductal lavage 47 imatinib resistance 47 neuroprotection 47 JMML 47 atherosclerotic disease 47 gemcitabine 47 Proxinium TM 47 receiving immunosuppressive therapy 47 deletion 5q 47 CYT# potent vascular disrupting 47 unresectable 47 mesenchymal 47 axillary lymph node dissection 47 Acute myeloid leukemia 47 anti angiogenic therapy 47 porcine islets 47 Hydroxyurea 47 erythropoietic 47 skeletal myoblasts 47 pancreatic resection 47 acute myeloid leukemia 47 myotonic dystrophy 47 MYLOTARG 47 Cyclosporine 47 granulocyte 47 transfemoral 47 Acute lymphoblastic leukemia 47 liposomal doxorubicin 47 insulin secreting beta 47 human leukocyte antigen 47 deferiprone 47 Myelodysplastic syndromes MDS 47 cardiac allograft vasculopathy 47 Amniocentesis 47 Pemphigus 47 gene rearrangements 47 Langerhans cell histiocytosis 47 mesenchymal cells 47 limb salvage 47 corneal graft 47 pancreas transplant 47 PGRN 47 relapsing remitting MS RRMS 47 Bone marrow transplants 47 limbal stem cell 47 bronchogenic carcinoma 47 ALDH br cells 47 biotherapies 47 idiopathic thrombocytopenic purpura 47 genotoxic stress 47 cancer mCRC 47 transcatheter aortic valve 47 sunitinib Sutent 47 mitral valve replacement 47 nasopharyngeal carcinoma 47 transplants 47 biochemical recurrence 47 bone marrow suppression 47 anti CD3 antibody 47 coronary arteriography 47 Everolimus 47 Critical Limb Ischemia CLI 47 azacytidine 47 engineered bladders 47 intraocular lens implantation 47 HNSCC 47 systemic lupus erythematosus 47 SCNT 47 platelet transfusion 47 BCL#A 47 immunosuppressant drug 47 primary hyperparathyroidism 47 Leukemias 47 medically inoperable 47 clonogenic 47 MitraClip device 47 retinal dystrophies 47 reprogrammed cells 47 immunosuppressant therapy 47 human neural stem 47 lenalidomide dexamethasone 47 mixed hyperlipidemia 47 Radioimmunotherapy 47 lymphadenectomy 47 epigenetic therapies 47 hematologic toxicity 47 hormonal therapy 47 Vidofludimus 47 calcineurin inhibitors 47 endoscopic resection 47 karyotyping 47 HCV infected 47 placental cells 47 intravesical instillation 47 immune modulation 47 IPSCs 47 palliative radiotherapy 47 Endothelial 47 opioid analgesia 47 post surgical adhesions 47 heavily pretreated patients 47 degenerative retinal diseases 47 cytomegalovirus CMV 47 myeloma cells 47 organ transplantations 47 myeloma 47 preoperative chemotherapy 47 underwent liver transplantation 47 angiogenesis inhibitor 47 retinal pigment epithelium 47 intraperitoneal chemotherapy 47 organogenesis 47 pheochromocytoma 47 vincristine 47 K ras mutations 47 HQK 47 ovulation induction 47 paricalcitol 47 XmAb# 47 Kantarjian 47 AQ4N 47 renal cell carcinoma 47 Sjögren syndrome 47 synthetic retinoid 47 Eliezer Zomer Ph.D. 47 therapy 47 metastatic cancer 47 meniscectomy 47 transplanted islet cells 47 uterine fibroid 47 Factor IX 47 androgen ablation 47 glioblastomas 47 renal fibrosis 47 perioperative morbidity 47 thyroid hormone receptor 47 hepatoma 47 surgical interventions 47 Hereditary angioedema HAE 47 trastuzumab 47 vinorelbine 47 aneuploidy 47 prostate TURP 47 Systemic lupus erythematosus 47 grade glioma 47 stem progenitor cells 47 tumor immunology 47 pegylated interferon alfa 47 colostomies

Back to home page